Randomized-controlled study of isophane and aspart insulin versus glargine and aspart insulin to treat prednisolone-induced hyperglycaemia in hospitalized patients

被引：0
|
作者：
Radhakutty, Anjana [1 ,2 ,3 ]
Stranks, Jessica L. [1 ]
Mangelsdorf, Brenda L. [1 ]
Drake, Sophie M. [1 ]
Roberts, Gregory W. [3 ,4 ]
Zimmermann, Anthony [2 ]
Stranks, Stephen N. [1 ]
Thompson, Campbell H. [3 ,5 ]
Burt, Morton G. [1 ,3 ]
机构：
[1] Repatriat Gen Hosp, Southern Adelaide Diabet & Endocrine Serv, Adelaide, SA, Australia
[2] Lyell McEwin Hosp, Endocrinol, Adelaide, SA, Australia
[3] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia
[4] Flinders Med Ctr, Dept Pharm, Adelaide, SA, Australia
[5] Univ Adelaide, Discipline Med, Adelaide, SA, Australia
来源：
CLINICAL ENDOCRINOLOGY | 2017年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
174
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [31] Efficacy of Insulin Degludec/Insulin Aspart (IDegAsp) vs. Insulin Glargine (IGlarU300) in Insulin-Naïve Patients with Type 2 Diabetes: A Retrospective Study
    Hasnani, Dhruvi
    Jha, Santosh
    Saboo, Banshi
    Prasanna, Pusala Lakshmi
    Sanghvi, Ami
    Sowani, Alpana
    Chavda, Vipul
    CLINICAL DIABETOLOGY, 2024, 13 (01): : 67 - 75
  • [32] The efficacy and safety of insulin glargine 100 U/mL + lixisenatide versus insulin degludec plus insulin aspart in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli-D randomized controlled trial
    Mu, Yiming
    DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 5497 - 5499
  • [33] Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart
    Ihlo, C. A.
    Lauritzen, T.
    Sturis, J.
    Skyggebjerg, O.
    Christiansen, J. S.
    Laursen, T.
    DIABETIC MEDICINE, 2011, 28 (02) : 230 - 236
  • [34] Long-term evaluation of the cost-effectiveness of biphasic insulin aspart 30 versus insulin glargine in poorly controlled patients with type 2 diabetes receiving oral antidiabetic agents
    Cobden, D
    Palmer, A
    Nicklasson, L
    Roze, S
    Garber, A
    DIABETOLOGIA, 2005, 48 : A336 - A336
  • [35] Response to Jovanovic for the Comments on Our Study "Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial"
    van Bon, Arianne C.
    DeVries, J. Hans
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (08) : 871 - 871
  • [36] Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT
    Strojek, Krzysztof
    Bebakar, Wan M. W.
    Khutsoane, Duma T.
    Pesic, Milica
    Smahelova, Alena
    Thomsen, Henrik F.
    Kalra, Sanjay
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 2887 - 2894
  • [37] Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study
    Balaji, Vijayam
    Balaji, Madhuri S.
    Alexander, Cynthia
    Srinivasan, Ashalata
    Suganthi, Sheela R.
    Thiyagarajah, Arthi
    Seshiah, Veerasamy
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (07) : 529 - 532
  • [38] Comparison of Insulin Detemir and Insulin Glargine in a Basal-Bolus Regimen, With Insulin Aspart as the Mealtime Insulin, in Patients With Type 1 Diabetes: A 52-Week, Multinational, Randomized, Open-Label, Parallel-Group, Treat-to-Target Noninferiority Trial
    Heller, Simon
    Koenen, Christoph
    Bode, Bruce
    CLINICAL THERAPEUTICS, 2009, 31 (10) : 2086 - 2097
  • [39] A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The merit study
    Guo, Lixin
    Chen, Li
    Chang, Baocheng
    Yang, Liyong
    Liu, Yu
    Feng, Bo
    DIABETES OBESITY & METABOLISM, 2018, 20 (12): : 2740 - 2747
  • [40] Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
    Cho, Kyu Yong
    Nakamura, Akinobu
    Oba-Yamamoto, Chiho
    Tsuchida, Kazuhisa
    Yanagiya, Shingo
    Manda, Naoki
    Kurihara, Yoshio
    Aoki, Shin
    Atsumi, Tatsuya
    Miyoshi, Hideaki
    DIABETES & METABOLISM JOURNAL, 2020, 44 (04) : 532 - +
12345